Mirum Pharmaceuticals (NASDAQ: MIRM) revenue
Mirum Pharmaceuticals reported revenue of $521.3m for fiscal 2025, 54.7% more than in fiscal 2024 ($336.9m).
Mirum Pharmaceuticals has grown its revenue for 4 years in a row, and fiscal 2025 is the highest of its 6 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $521.3m | +54.7% | −$22.1m | −4.2% |
| 2024 | $336.9m | +80.8% | −$87.6m | −26.0% |
| 2023 | $186.4m | +141.8% | −$109.2m | −58.6% |
| 2022 | $77.1m | +302.7% | −$131.2m | −170.3% |
| 2021 | $19.1m | — | −$173.4m | −906.1% |
| 2020 | $0.0m | — | −$104.3m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Mirum Pharmaceuticals revenue compared with its sector
By revenue for its latest fiscal year, Mirum Pharmaceuticals ranks 189th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Mirum Pharmaceuticals, 54.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 187th | Bioventus | $568.1m | −0.9% |
| 188th | AtriCure | $534.5m | 14.9% |
| 189th | Mirum Pharmaceuticals | $521.3m | 54.7% |
| 190th | Veracyte | $517.1m | 16.0% |
| 191st | ADMA Biologics | $510.2m | 19.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Mirum Pharmaceuticals
- How much revenue did Mirum Pharmaceuticals make in fiscal 2025?
- Mirum Pharmaceuticals reported revenue of $521.3m for fiscal 2025, compared with $336.9m in fiscal 2024.
- What was the best year for revenue at Mirum Pharmaceuticals?
- Of its last 6 fiscal years, fiscal 2025, with $521.3m.
- Where does Mirum Pharmaceuticals rank in its sector by revenue?
- It ranks 189th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Mirum Pharmaceuticals come from?
- From the annual report (Form 10-K) that Mirum Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Mirum Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Mirum Pharmaceuticals: the Mirum Pharmaceuticals page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.